Showing results (41-50 of 179) with videos related to
Sort By:
Pageof 18
The Journal of Organic Chemistry|August 21, 2007
A new series of 3-alkyl phosphate derivatives of 4,5,6,7-tetrahydro-1-D-ribityl-1H-pyrazolo[3,4-d]pyrimidinedione as inhibitors of lumazine synthase: design, synthesis, and evaluationYanlei Zhang, Guangyi Jin, Boris Illarionov, et al.The Journal of Organic Chemistry|January 31, 2004
Design, synthesis, and evaluation of 9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthaseMark Cushman, Thota Sambaiah, Guangyi Jin, et al.Journal of Medicinal Chemistry|March 10, 2015
Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activitiesWei Lv, Jinzhong Liu, Todd C Skaar, et al.Journal of Medicinal Chemistry|October 4, 2002
Synthesis and investigation of conformationally restricted analogues of lavendustin A as cytotoxic inhibitors of tubulin polymerizationFanrong Mu, Debbie J Lee, Donald E Pryor, et al.The Journal of Organic Chemistry|October 25, 2001
Synthesis and Biochemical Evaluation of Bis(6,7-dimethyl-8-D-ribityllumazines) as Potential Bisubstrate Analogue Inhibitors of Riboflavin SynthaseMark Cushman, Farahnaz Mavandadi, Donglai Yang, et al.Journal of Medicinal Chemistry|December 12, 2003
Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogenMuthukaman Nagarajan, Xiangshu Xiao, Smitha Antony, et al.The Journal of Organic Chemistry|October 9, 2004
Design, synthesis, and evaluation of acyclic C-nucleoside and N-methylated derivatives of the ribitylaminopyrimidine substrate of lumazine synthase as potential enzyme inhibitors and mechanistic probesJinhua Chen, Thota Sambaiah, Boris Illarionov, et al.Journal of Medicinal Chemistry|May 28, 2004
Design, synthesis, anti-HIV activities, and metabolic stabilities of alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitorsMaximilian A Silvestri, Muthukaman Nagarajan, Erik De Clercq, et al.Journal of Medicinal Chemistry|January 5, 2002
Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal modelMuthusamy Jayaraman, Brian M Fox, Melinda Hollingshead, et al.Journal of Medicinal Chemistry|March 27, 2015
Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitorsTrung Xuan Nguyen, Monica Abdelmalak, Christophe Marchand, et al.Pageof 18